Cargando…
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the bra...
Autores principales: | Pinheiro, Rúben G. R., Coutinho, Ana Joyce, Pinheiro, Marina, Neves, Ana Rute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584083/ https://www.ncbi.nlm.nih.gov/pubmed/34769082 http://dx.doi.org/10.3390/ijms222111654 |
Ejemplares similares
-
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
Cerebellar dysfunction and autism spectrum disorders – what do we know?
por: Pinheiro Ramos, C., et al.
Publicado: (2023) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)